SCHEMBL149795

SCHEMBL149795

C=C1CC=CC=C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205153 0.74
SCHEMBL1325233 0.72
SCHEMBL1068225 0.72
SCHEMBL208011 0.72
SCHEMBL6425143 0.70
SCHEMBL4595181 0.70
SCHEMBL4926419 0.69
SCHEMBL10316868 0.68
SCHEMBL13214488 0.68
SCHEMBL10564790 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704832-A2 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS Biohaven Therapeutics Ltd. (VG) 2026-03-11 EP claimed
US-20260015402-A1 SMALL MOLECULE ADAPTER REGULATED, TARGET SPECIFIC CHIMERIC ANTIGEN RECEPTOR BEARING T CELLS (SMART CARS) YALE UNIVERSITY 2026-01-15 US claimed
WO-2025081133-A2 BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EXTRACELLULAR PROTEINS IN THE BRAIN YALE UNIVERSITY (US) 2025-04-17 WO claimed
CN-118978694-A Calixarene-based crosslinked polymer, and synthetic method and application thereof 深圳市地博环保科技有限公司 2024-11-19 CN claimed
WO-2024227119-A2 BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-10-31 WO claimed
US-12083181-B2 Bi-functional molecules to degrade circulating proteins YALE UNIVERSITY (US) 2024-09-10 US claimed
WO-2024167879-A1 BIFUNCTIONAL MOLECULES TO TARGET DEGRADATION OF INTERLEUKIN 17A (IL-17A) BIOHAVEN THERAPEUTICS LTD. (VG) 2024-08-15 WO claimed
WO-2024167900-A2 BIFUNCTIONAL MOLECULES TO TARGET DEGRADATION OF TUMOR NECROSIS FACTOR BIOHAVEN THERAPEUTICS LTD. (VG) 2024-08-15 WO claimed
US-20240050578-A1 BI-FUNCTIONAL MOLECULES TO DEGRADE CIRCULATING PROTEINS UNIV YALE (US) 2024-02-15 US claimed
US-11767301-B2 Bi-functional molecules to degrade circulating proteins YALE UNIVERSITY (US) 2023-09-26 US claimed
WO-1998036015-A1 REDISTRIBUTION OF POLYPHENYLENE ETHERS AND POLYPHENYLENE ETHERS WITH NOVEL STRUCTURE GENERAL ELECTRIC COMPANY (US) 1998-08-20 WO claimed
EP-0715619-A4 INHIBITORS OF TNF-ALPHA SECRETION IMMUNEX CORP (US) 1997-03-19 EP claimed
US-5594106-A Inhibitors of TNF-α secretion IMMUNEX CORPORATION (US) 1997-01-14 US claimed
EP-0715619-A1 INHIBITORS OF TNF-ALPHA SECRETION IMMUNEX CORPORATION (US) 1996-06-12 EP claimed
US-5510420-A NUCLEOPHILIC GRAFTING OF PARENT POLYMER HAVING AROMATIC RINGS CONTAINING REACTIVE GROUPS HOECHST CELANESE CORPORATION (US) 1996-04-23 US claimed
CN-1118193-A Novel matrix resin for high-temperature stable photoimageable compositions HOECHST CELANESE CORP (US) 1996-03-06 CN claimed
EP-0686274-A1 NOVEL MATRIX RESIN FOR HIGH-TEMPERATURE STABLE PHOTOIMAGEABLE COMPOSITIONS HOECHST CELANESE CORPORATION (US) 1995-12-13 EP claimed
WO-1995006031-A1 INHIBITORS OF TNF-ALPHA SECRETION IMMUNEX CORPORATION (US) 1995-03-02 WO claimed
WO-1994019724-A1 NOVEL MATRIX RESIN FOR HIGH-TEMPERATURE STABLE PHOTOIMAGEABLE COMPOSITIONS HOECHST CELANESE CORPORATION (US) 1994-09-01 WO claimed
EP-0379773-A1 Thermally conductive electrically resistive diamond filled epoxy adhesive DIGITAL EQUIPMENT CORPORATION (US) 1990-08-01 EP claimed